Indegene Completes Internal Merger of Wholly Owned German Subsidiaries
Indegene Ltd · Others (Uncategorized) · 11 Sept 2026, 1:20 am
Indegene Completes Internal Merger of Wholly Owned German Subsidiaries Indegene Limited announced the merger of its indirect wholly owned subsidiaries in Germany, Indegene Healthcare Germany GmbH and Trilogy Writing & Consulting GmbH, effective 9th Sep'26. Following the merger, Trilogy Writing & Consulting GmbH emerged as the surviving entity and was subsequently renamed Indegene Healthcare Germany GmbH. The surviving entity's projected revenue for FY26-27 stands at €20.10mn. Undertaken as an internal restructuring, the transaction involves no cash consideration, share exchange, or change in Indegene's shareholding pattern, with no material impact on the company's financials or business operations.
Original exchange filing (PDF)
More announcements from Indegene Ltd
- Intimation of Investors / Analysts Meeting · 06 Nov 2026
- Transcript of the Q2 FY27 Earnings Call · 04 Nov 2026
- Audio Recording of the Q2 FY27 Earnings Call · 30 Oct 2026
- Audio Recording of the Q2 FY27 Earnings Call · 30 Oct 2026
- Analyst Presentation and Fact Sheet - financial results for the 2nd quarter and half year ended 30th September, 2026 · 30 Oct 2026
- Press Release · 30 Oct 2026
- Indegene Limited has informed the Exchange regarding Resignation of Ms Srishti Ramesh Kaushik as Company Secretary & Compliance Officer of the company w.e.f. December 02, 2026. · 30 Oct 2026
- Intimation of Resignation of Ms. Srishti Ramesh Kaushik (M. No A21609) from the position of Company Secretary, Compliance Officer and Key Managerial Personnel of the Company. · 30 Oct 2026
